REGISTERED
on 14 Nov 2023
Last Applicant/ Owned by
2100 Powell Street, Suite 720
Emeryville
CA
94608
Serial Number
97518582 filed on 25th Jul 2022
Registration Number
7220140 registered on 14th Nov 2023
Correspondent Address
Beth M. Goldman ORRICK, HERRINGTON & SUTCLIFFE LLP
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
DYNAVAX
Color is not claimed as a feature of the mark. DYNA VAX; DYNA VACCINE Pharmaceutical preparations for the prevention and treatment of hepatitis, chronic viral infections, viruses and other infectious diseases, disorders, symptoms and syndromes, inflammatory diseases, disorders, symptoms and syndromes, genetic diseases, disorders, symptoms and syndromes, neurological diseases, disorders, symptoms Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the prevention and treatment of hepatitis, chronic viral infections, viruses and other infectious diseases, disorders, symptoms and syndromes, inflammatory diseases, disorders, symptoms and syndromes, genetic diseases, disorders, symptoms and syndromes, neurological diseases, disorders, symptoms and syndromes, allergic and autoimmune diseases, disorders, symptoms and syndromes, immune system diseases, disorders, symptoms and syndromes, cancer; vaccines; vaccine adjuvants
First Use Date in General
17th Jan 2018
First Use Date in Commerce
17th Jan 2018
Mark Details
Serial Number
No 97518582
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 21557-1
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Description of Design Search
The mark consists of the word "DYNAVAX" in stylized lettering.
Legal History
| Status Date | Action Taken |
|---|---|
| 14th Nov 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 14th Nov 2023 | REGISTERED-PRINCIPAL REGISTER |
| 07th Oct 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 06th Oct 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 30th Aug 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 30th Aug 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 23rd Aug 2023 | USE AMENDMENT FILED |
| 23rd Aug 2023 | TEAS STATEMENT OF USE RECEIVED |
| 15th Aug 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 20th Jun 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |